Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × Panitumumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 24 Neoplasm Metastasis 6 Neoplasms 5 Colonic Neoplasms 4 Triple Negative Breast Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Advanced Solid Tumors 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Inflammatory Breast Neoplasms 1 Glioma 1 Fallopian Tube Neoplasms 1 Erythema 1 Endometrial Neoplasms 1 Edema 1 Dihydropyrimidine Dehydrogenase Deficiency 1 Colorectal Cancer Metastatic 1 Brain Neoplasms 1

Interventions

Bevacizumab 8 Capecitabine 4 Fluorouracil 3 Cetuximab 3 trifluridine tipiracil drug combination 2 Nivolumab 2 sintilimab 1 regorafenib 1 irinotecan sucrosofate 1 folfirinox 1 balstilimab 1 anisodamine 1 Vemurafenib 1 Tomography, X-Ray Computed 1 Panitumumab 1 Oxaliplatin 1 Liver Transplantation 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Folfox protocol 1 Doxorubicin 1 Dexamethasone 1 Decitabine 1 2-(phenylmethyl)-1-naphthol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06332079 2026-01-05

HAITI

Gruppo Oncologico del Nord-Ovest

Phase 2 Terminated

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡